search
Back to results

Ultrasound-guided Interscalene Block:3mL Ropi Provide Similar Analgesia to 5mL and Less Diaphragmatic Paralysis

Primary Purpose

Diaphragmatic Paralysis

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Ropivacaine 0.5% Injectable Solution
Sponsored by
Saint George Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Diaphragmatic Paralysis

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • ASA1-2

Exclusion Criteria:

  • ASA3-4 anticoagulant

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    3 ml ropivacaine

    5 ml ropivacaine

    Arm Description

    interscalene block using 3 ml under ultrasound put medication on each nerve

    interscalene block using 5 ml under ultrasound put medication on each nerve

    Outcomes

    Primary Outcome Measures

    Diaphragmatic paralysis
    on x ray we look if there is an elevated diaphragm
    Pain relief
    pain scale 1-10 score 1 no pain and 10 severe pain first by visiting patient before discharge twice and thereafter on the phone

    Secondary Outcome Measures

    Full Information

    First Posted
    January 23, 2019
    Last Updated
    March 20, 2020
    Sponsor
    Saint George Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04317235
    Brief Title
    Ultrasound-guided Interscalene Block:3mL Ropi Provide Similar Analgesia to 5mL and Less Diaphragmatic Paralysis
    Official Title
    Ropivacaine for Ultrasound-guided Interscalene Block: 3mL Provide Similar Analgesia to 5mL With Less Diaphragmatic Paralysis in Shoulder Arthroscopy Surgeries
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2020
    Overall Recruitment Status
    Completed
    Study Start Date
    January 10, 2016 (Actual)
    Primary Completion Date
    March 2, 2018 (Actual)
    Study Completion Date
    January 20, 2019 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Saint George Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Ropivacaine for ultrasound-guided interscalene block: 3mL provide similar analgesia to 5mL with less diaphragmatic paralysis in shoulder arthroscopy surgeries
    Detailed Description
    Ropivacaine for ultrasound-guided interscalene block: 3mL provide similar analgesia to 5mL with less diaphragmatic paralysis in shoulder arthroscopy surgeries with no toxicity and no adverse reaction or complications we targeted under echography each nerve to be blocked alone either to put around all the nerves a big volume

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Diaphragmatic Paralysis

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    60 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    3 ml ropivacaine
    Arm Type
    Active Comparator
    Arm Description
    interscalene block using 3 ml under ultrasound put medication on each nerve
    Arm Title
    5 ml ropivacaine
    Arm Type
    Active Comparator
    Arm Description
    interscalene block using 5 ml under ultrasound put medication on each nerve
    Intervention Type
    Drug
    Intervention Name(s)
    Ropivacaine 0.5% Injectable Solution
    Other Intervention Name(s)
    interscalene
    Intervention Description
    Is to put 3 ml or 5 ml and show the difference
    Primary Outcome Measure Information:
    Title
    Diaphragmatic paralysis
    Description
    on x ray we look if there is an elevated diaphragm
    Time Frame
    Up to 48 hours
    Title
    Pain relief
    Description
    pain scale 1-10 score 1 no pain and 10 severe pain first by visiting patient before discharge twice and thereafter on the phone
    Time Frame
    up to day 2 after operation

    10. Eligibility

    Sex
    All
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: ASA1-2 Exclusion Criteria: ASA3-4 anticoagulant
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    hazem kafrouni
    Organizational Affiliation
    Saint George Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Ultrasound-guided Interscalene Block:3mL Ropi Provide Similar Analgesia to 5mL and Less Diaphragmatic Paralysis

    We'll reach out to this number within 24 hrs